BeStock  
Stocks › AXSM

Axsome Therapeutics AXSM

US equityMarket cap rank #1751
$129.36 −$6.32 (-4.66%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $129.36 0.00%
Open$133.92
Prev close$135.68
Day range$128.23 – $135.09
Volume811.8K
Market cap$6.80B
P/E (TTM)–
Dividend yield–

AXSM Stock News

Headlines matching Axsome Therapeutics or the AXSM ticker, most recent first.

  • Deutsche Bank Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Cuts Target Price to $267 NegativeMarket news · 29 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Axsome Therapeutics(AXSM.US) With Hold Rating, Maintains Target Price $251Market news · 25 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $290Market news · 25 Sep 2026 · Direct mention
  • Truist Financial Initiates Axsome Therapeutics(AXSM.US) With Buy Rating, Announces Target Price $285Market news · 23 Sep 2026 · Direct mention
  • H.C. Wainwright Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)TipRanks · 22 Sep 2026 · Direct mention
  • Piper Sandler Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $258Market news · 18 Sep 2026 · Direct mention
  • RBC Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $297Market news · 18 Sep 2026 · Direct mention
  • BMO Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $310Market news · 14 Sep 2026 · Direct mention
  • Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $316Market news · 12 Sep 2026 · Direct mention
  • Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $306Market news · 4 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Raises Target Price to $316 PositiveMarket news · 13 Aug 2026 · Direct mention
  • Jefferies Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $380Market news · 12 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Axsome Therapeutics(AXSM.US), With a Forecast Between $251 to $315Market news · 11 Aug 2026 · Direct mention
  • RBC Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Cuts Target Price to $297 NegativeMarket news · 11 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Cuts Target Price to $306 NegativeMarket news · 31 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AXSM.

Sign in to join the discussion.

Scroll to Top